Johnson & Johnson at JPMorgan Healthcare Conference Transcript
Good morning. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting a fireside chat this morning with Joaquin Duato, who's assuming the CEO role at J&J earlier this year. So Joaquin, Happy New Year, and great to be speaking with you today.
Maybe just to kick off the conversation, and I know this is your first presentation to The Street as CEO, would love to hear about your top priorities as you move into the role.
Thank you, Chris, and thank you, everybody, for joining. As you can imagine, I am deeply honored to be the eighth CEO of this remarkable company, Johnson & Johnson. And I am very excited about taking the role now in what I think is a moment of opportunity for health care in which Johnson & Johnson, it's in a very good position to continue to create value and accelerate growth by focusing mainly on what has made us great, differentiation based on science and technology.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |